astleman disease (CD) is a rare benign lymphoproliferative disorder of unknown etiology, typically presenting as a solitary mediastinal mass. The head and neck is the most common site but involvement of the parotid gland is extremely rare. 1 Based on analysis of American databases, the incidence of CD is estimated as 21-25 cases per million personyears. 2 In this article, a patient who has mixed type CD causing a parotid mass is presented.
CASE REPORT
A 59 years old man admitted to our otorhinolaryngology clinic with a complaint of tinnitus. On physical examination, a painless swelling on his neck Castleman's Disease Mimicking a Parotid Gland Tumor A AB BS ST TR RA AC CT T Castleman disease (CD) is a rare benign lymphoproliferative disorder of unknown etiology, typically presenting as a solitary mediastinal mass. The head and neck region is the most common site; however, the salivary glands are rarely affected. We present a rare case of a 59-yearold male patient with mixed type CD localized in the parotid gland. The patient underwent a left superficial parotidectomy with a clinical prediagnosis of mucoepidermoid carcinoma. H&E stained sections showed mostly preserved lymph node architecture. Some lymphoid follicles had atrophic germinal centers and mantle zones was expanded. Also there were sclerotic blood vessels radially penetrated the germinal centers and the overall appearance of the follicle was resembling a lollipop. (Figure 1 ). Also there were sclerotic blood vessels radially penetrated the germinal centers and the overall appearance of the follicle was resembling a lollipop ( Figure 2 ). Immunohistochemically germinal centers showed positivity for CD23. There were vascular structures in the germinal centres of the follicles and CD34 positive blood vessels were extending out from the germinal centers in some follicles ( Figure 3 ).
Small lymphocytes, immunoblasts and sheets of CD138 positive mature plasma cells were seen at the interfollicular regions. Plasma cells showed polytypic light chain expression. Immunhistochemical analysis of HHV-8 was negative. The diagnosis was CD, mixed type. The same histologic findings were found in other lymph nodes in the neck dissection material. With the help of the clinical findings, the case was accepted as a multicentric CD. The patient was treated with cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) chemotherapy. Clinically and radiologically no recurrence was noted during a follow up period of 20 months.
DISCUSSION
Castleman's disease, also known as giant lymph node hyperplasia or angiofollicular lymph node hyperplasia, was first defined in 1954 by Castleman and his colleagues.
3 It usually appears as a mediastinal, cervical, mesenteric, or retroperitoneal mass. 4 Commonly the disease is located in the mediastinum (60%), and head and neck area accounts for 14% of cases.
1 CD of the parotid gland is an extremely rare entity, with only 26 cases reported in the English literature. 5, 6 CD has 2 histologic types; hyaline vascular and plasma cell. Cases with mixed histological features have also been reported. 7, 8 There are 2 clinical types: localized and multicentric. 9 Sümeyye EKMEKÇİ et al.
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FIGURE 2:
Sclerotic blood vessels radially penetrated the germinal centerslollipop follicles (HE, x100).
FIGURE 2: CD34 positive blood vessels (CD34, x100).
Hyaline vascular CD is mostly observed in young adults with a mean age of 30-40 years and constitutes 90% of all CD cases. 1 Plasma cell variant as the less common form is a diagnosis of exclusion and is not well-defined histologically. The plasma cell variant is frequently associated with constitutional symptoms, cytopenias, hypergammaglobulinemia, splenomegaly, and increased IL-6 levels, and tend to be multicentric.
The microscopic examination of the lymph nodes reveal mostly preserved architecture, follicular hyperplasia in variable rate, and prominent paracortical plasmacytosis. 2 The wide spectrum of clinical manifestations cause challenge in the diagnosis. The disease has no specific clinical, radiological, or cytological features. It is a diagnosis of exclusion with the aid of histopathological examination. Therefore, it is important for the physicians to be aware of this clinical entity so patients can receive adequate and early treatment. Surgery is the treatment of choice for the solitary form 1 , whereas chemotherapy, radiotherapy and steroids are proposed for the multicentric type and inoperable cases.
Radiation therapy (RT) is an appropriate option for masses that cannot be resected by surgery. RT can be a definitive treatment modality for unicentric CD with a succesfull control rate and few complications. 8 The differential diagnosis includes Warthin tumor, pleomorphic adenoma, schwannoma, hemangioma, lymphangioma, teratoma, sarcoma and metastatic nodes. 6, 10 The prognosis of CD is variable and depends predominantly on disease subtype. 2 Because of its unusual location and tendency to mimic other neoplasms, parotid gland CD presents considerable diagnostic difficulties. Radiological findings are beneficial, but not diagnostic. 5 CD is a heterogeneous disorder that can represent a continuous spectrum of disease or several different diseases all together; clinically it might be asymptomatic or could be lethal, The final diagnosis could be achived by histopathological evaluation, The treatment has to be surgery which appears to be curative in local lesions; in inoperable or systemic variants the treatment is radiation therapy and chemotherapy. 10 It is important to remember this entity for enlarged lymph nodes even in extreme localizations.
S So ou ur rc ce e o of f F Fi in na an nc ce e During this study, no financial or spiritual support was received neither from any pharmaceutical company that has a direct connection with the research subject, nor from a company that provides or produces medical instruments and materials which may negatively affect the evaluation process of this study. Sümeyye Ekmekci, Gülen Gül, Ebru Çakır; C Co on nt tr ro ol l/ /S Su up pe er rv vi is si io on n: : Ebru Çakır, Sermin Özkal; D Da at ta a C Co ol ll le ec ct ti io on n a an nd d/ /o or r P Pr ro oc ce es ss si in ng g: : Sümeyye Ekmekci, Ülkü Küçük, Suat Kaptaner; A An na al ly ys si is s a an nd d/ /o or r I In nt te er rp pr re et ta at ti io on n: : Sümeyye Ekmekci, Ülkü Küçük, Dudu Solakoğlu Kahraman; L Li it te er ra at tu ur re e R Re ev vi ie ew w: : Sümeyye Ekmekci, Gülen Gül, Ülkü Küçük, Ebru Çakır, Dudu Solakoğlu Kahraman; W Wr ri it ti in ng g t th he e A Ar rt ti ic cl le e: : Sümeyye Ekmekci, Ebru Çakır, Gülen Gül; C Cr ri it ti ic ca al l R Re ev vi ie ew w: : Ebru Çakır, Sermin Özkal; R Re ef fe er re en nc ce es s a an nd d F Fu un nd di in ng gs s: : Sümeyye Ekmekci, Gülen Gül; M Ma at te er ri ia al ls s: : Sümeyye Ekmekci, Ülkü Küçük, Suat Kaptaner.
